FDA Approves Optune Lua for Metastatic Non–Small Cell Lung Cancer, While Funding and Oncology Advances Dominate the Biopharma Landscape New device approval and robust oncology funding highlight ongoing biopharma momentum in cancer therapies. 12 months ago By John In Breakthroughs,Clinical Trials,Funding Rounds,Innovation,Technology,Top Stories,Venture Capital,
